NC
HCAT icon

nVerses Capital’s Health Catalyst HCAT Stock Holding History

nVerses Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,341
Closed -$24.7K – 414
2025
Q4 		$24.7K Buy
+10,341
New +$28.3K 0.06% 196
2024
Q4 		– Sell
-7,300
Closed -$59.4K – 367
2024
Q3 		$59.4K Buy
+7,300
New +$52.8K 0.03% 589

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

nVerses Capital's HCAT Position: Q1 2026 in Review

nVerses Capital sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 10,341 shares — an estimated $24.7K sold.

nVerses Capital first reported a position in HCAT in Q3 2024 and held it in 2 quarters. The position peaked at $59.4K in Q3 2024. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • nVerses Capital reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • nVerses Capital sold 10,341 Health Catalyst shares in Q1 2026, an estimated $24.7K.
  • nVerses Capital first reported a position in Health Catalyst in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Health Catalyst position peaked at $59.4K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.